Drug intelligence / Profile preview

polyethylene glycol 400 + propylene glycol + hydroxypropyl-guar

Development stage
Unknown
Lead developer
Alcon
Modality
Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Ophthalmic
01

Overview

This drug is a combination ophthalmic formulation containing polyethylene glycol 400 (PEG 400), propylene glycol, and hydroxypropyl-guar. It is used as an artificial tear or lubricant eye drop for the temporary relief of burning and irritation due to dry eyes. Polyethylene glycol 400 and propylene glycol act as lubricants that mimic natural tears to moisten the ocular surface and reduce symptoms of dryness[1][2][7]. Hydroxypropyl-guar is a derivative of guar gum that acts as a viscosity-enhancing agent; it forms a gel-like matrix on the eye surface which helps stabilize the tear film and prolongs retention time of the lubricants[6]. The combination restructures and stabilizes all three layers of the tear film (mucin, aqueous, lipid), reduces evaporation/drainage of tears, provides symptomatic relief from environmental or medical causes of dry eye disease[7].

Brand names
Systane Gel DropsSystane Preservative-FreeSystane Lubricant Eye DropsSystane Ultra Preservative-Free
Other names
PEG 400 + propylene glycol + hydroxypropyl-guarPEG-400/propylene glycol/hydroxypropyl guar ophthalmic solution

Beyond the preview

Go deeper on polyethylene glycol 400 + propylene glycol + hydroxypropyl-guar.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polyethylene glycol 400 + propylene glycol + hydroxypropyl-guar.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call